Stocks Comparison
Avanos Medical vs Edwards Lifesciences: revenue, profit, margins and growth compared
Avanos Medical brought in $701.2M of revenue in fiscal 2025, Edwards Lifesciences $6.1B in fiscal 2025. Revenue changed by +1.9% at Avanos Medical and +11.5% at Edwards Lifesciences on the year before, so Edwards Lifesciences grew faster. Avanos Medical kept -10.4% of its revenue as net profit, Edwards Lifesciences 17.7%. Free cash flow was $43.1M at Avanos Medical and $1.3B at Edwards Lifesciences.
Side by side, latest fiscal year
| AVNS | EW | |
|---|---|---|
| Fiscal year ended | FY2025 (December 31, 2025) | FY2025 (December 31, 2025) |
| Revenue | $701.2M | $6.1B |
| Revenue growth | +1.9% | +11.5% |
| Net income | -$72.9M | $1.1B |
| Net margin | -10.4% | 17.7% |
| Free cash flow | $43.1M | $1.3B |
| Free cash flow margin | 6.1% | 22.0% |
| Earnings per share (diluted) | -$1.57 | $1.83 |
| Cash | $89.8M | $2.9B |
| Debt | $90.3M | $598.3M |
| Price to earnings | n/a | 47.1 |
| Market value | n/a | $49.7B |
| Dividend yield | n/a | n/a |
| Rank by revenue in sector | #175 of 646 · Health care | #55 of 646 · Health care |
Over the years
Questions about Avanos Medical and Edwards Lifesciences
Which is bigger by revenue, Avanos Medical or Edwards Lifesciences?
Edwards Lifesciences is bigger by revenue: $6.1B in fiscal 2025, against $701.2M for Avanos Medical in fiscal 2025.
Which keeps more of its revenue as profit, Avanos Medical or Edwards Lifesciences?
Avanos Medical had a net margin of -10.4% in fiscal 2025; Edwards Lifesciences had 17.7% in fiscal 2025.
Which grew revenue faster, Avanos Medical or Edwards Lifesciences?
In their latest fiscal years revenue changed by +1.9% at Avanos Medical and +11.5% at Edwards Lifesciences.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.